Abstract

Patient-directed selection and optimization of electrical-based neuromodulatory therapy (i.e., Spinal Cord Stimulation [SCS]) for treatment of chronic pain is increasingly thought to be an important capability given the subjective and varying nature of the experience of pain. As such, a new device capable of full-body MRI is now commercially available to patients that enables the utilization of paresthesia-based and sub-perception-based neurostimulative modalities. Here – we describe outcomes from patients using this newly available SCS system as part of an observational, real-world clinical evaluation.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call